José Luis Ferreiro: After Stent Treatment in Heart Attack Patients How to Balance Bleeding and Clotting Risk
José Luis Ferreiro, Head of the Department of Cardiology at Hospital Universitari Joan XXIII, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Happy to share this new Clinical Consensus Statement led by the ESC Working Group on Thrombosis in collaboration with ACCA, EAPCI and Working Group on Cardiovascular Pharmacotherapy
Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks.
Simultaneous publication in European Heart Journal: Acute Cardiovascular Care and EuroIntervention
Discussing alternative antithrombotic strategies to standard DAPT to reduce bleeding (DAPT abbreviation and de-escalation) or ischaemic (prolonged DAT) risk and some guidance to individualize therapy.”
Erik Lerkevang Grove, Cardiologist at Aarhus University Hospital, Skejby shared this post on LinkedIn, adding:
”Proud to be part of this important and comprehensive consensus document:
Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks
Simultaneous publication in European Heart Journal: Acute Cardiovascular Care and EuroIntervention.”
Title: Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks: A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology
Authors: Diana A Gorog, Jurrien M ten Berg, Gianluca Campo, Tobias Geisler, Bruna Gigante, Erik L Grove, Sigrun Halvorsen, Kurt Huber, Young-Hoon Jeong, Gregory Y H Lip, Eliano P Navarese, Andrea Rubboli, Jolanta M Siller Matula, Robert F Storey, Marco Valgimigli, Christophe Vandenbriele, Gemma Vilahur, Ingo Ahrens, Jose Luis Ferreiro
Read the Full Article on European Heart Journal Acute Cardiovascular Care
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 10, 2026, 15:54Niccolò Bitto: Answers to Some of the Most Frequently Asked Questions on Gene Therapy for Hemophilia
-
Apr 10, 2026, 15:52Tareq Abadl: Coombs Test Explained in a Simple and Clear Way
-
Apr 10, 2026, 15:10Jecko Thachil: Should We Consider Air Pollution as a Thrombophilic Marker?
-
Apr 10, 2026, 14:02Pablo Corral: Are Cholesterol and Inflammation Really Equal in Atherosclerosis?
-
Apr 10, 2026, 13:43Mohammed Alo։ How Low Should LDL Go in Secondary Prevention of Cardiovascular Disease
-
Apr 10, 2026, 13:21John Abraham: Telomere Biology Disorders – From Bench to Bedside
-
Apr 10, 2026, 01:19Heghine Khachatryan: When Vascular Fragility Defines Risk – Rethinking Hemostasis in LDS
-
Apr 9, 2026, 21:39Mechanisms of Immune Dysregulation in Immune Thrombocytopenia – JTH
-
Apr 9, 2026, 21:37Arun V J: The Nation Inside the Human Body and Blood Function